The Hidden Tax on Healthcare Is Not Fraud, It Is Affiliation

The strange thing about healthcare is that size keeps winning, even when it looks inefficient

What if the biggest driver of healthcare inflation is not medical need, not patient behavior, and not even traditional pricing power, but where the doctor sits inside the corporate map?

That is the uncomfortable pattern hiding in plain sight. On one side, a major insurer posts rising operating profit, stable loss ratios, and strong valuation. On the other side, primary care is increasingly pulled into hospital systems, and hospital affiliated practices are paid more than independent ones. Put those two realities together and a deeper picture emerges: healthcare is not merely a market for care, it is a market for position. The winners are often not the best clinicians or the most efficient operators. They are the organizations that can control routing, contracting, and reimbursement geography.

That changes the question entirely. Instead of asking why healthcare costs so much, we should ask a harder question: What exactly is being rewarded when money moves through the system?

Healthcare is not one market, it is a stack of gated markets

Most people imagine healthcare as a simple exchange: a patient gets care, an insurer pays, and the provider delivers. In reality, the industry is more like a layered toll road. Each layer can charge something, steer something, or block something. The important insight is that reimbursement does not just reflect clinical complexity. It also reflects organizational topology.

When nearly half of primary care practices are hospital affiliated, that is not just a statistic about ownership. It signals a change in bargaining power. A hospital affiliated practice often has access to higher reimbursement, more referrals, and stronger negotiating leverage. An independent physician practice may be just as good clinically, but it occupies a weaker node in the network. In a fragmented system, the map matters as much as the medicine.

In healthcare, the unit of power is not the doctor or even the hospital. It is the controlled pathway between them.

That is why the earnings picture matters. A large insurer can report a slightly lower loss ratio, modest revenue growth, and improved operating profit even while membership shifts and segments change. This does not necessarily mean the system is becoming more efficient for patients. It may simply mean value is being captured more effectively by the entities that sit at the junctions between patients, providers, and payers.

The hidden logic is familiar if you think of railroads, ports, or app stores. The richest actors are rarely the ones doing the most visible work. They are the ones controlling access, pricing, and routing. Healthcare increasingly behaves the same way.

---

The real competition in healthcare is for reimbursement position, not just patients

A basic mistake in healthcare analysis is to treat revenue growth as evidence of broad health in the system. It is more precise to say revenue growth often reflects who got positioned to collect it.

Consider the contrast embedded in the numbers. One large payer platform is growing operating profit while its membership mix shifts away from some lines and toward others. Meanwhile, primary care is being absorbed into hospital systems, and hospital affiliated practices are receiving higher reimbursement than independent ones. These are not disconnected events. They are two sides of the same economic transformation: healthcare is consolidating into larger entities that can negotiate from strength.

Think of a neighborhood where every small store eventually gets bought by a few big chains. The products on the shelves may not change much. But the pricing architecture changes dramatically. The chain can demand better terms from suppliers, place stores in premium spots, and spread overhead across a wider base. Healthcare consolidation works similarly, except the product is care, the supplier is labor, and the customer is often confused, insured, and desperate.

This is why reimbursement gaps matter so much. An 11 percent payment premium for hospital affiliated practices is not a minor accounting quirk. It is a compounding advantage. It can help fund more staff, more technology, more negotiating power, and more acquisition of smaller practices. Over time, that creates a flywheel: higher reimbursement supports further consolidation, and consolidation justifies further higher reimbursement.

Private equity getting 8 percent higher reimbursements tells a similar story. The system is not simply paying for medical outcomes. It is paying for organizational form. If your structure allows you to optimize coding, negotiate contracts, or bundle services more effectively, you may earn more, regardless of whether patients are healthier.

That is the uncomfortable tension at the center of modern healthcare. The system rewards entities that can become larger, more integrated, and more strategic, even when the public narrative still says it rewards quality and access.

---

Why this can look efficient from the outside while becoming less efficient inside

This is where many observers get confused. A company can improve profits, stabilize ratios, and increase market value while the underlying system becomes more distorted. In fact, that is often how distortion first appears: as financial discipline.

A lower loss ratio sounds good because it suggests underwriting discipline or better medical management. But a lower loss ratio can also reflect more selective member mix, more favorable contract structures, or better control over where care flows. Likewise, rising operating profit may mean the company is becoming more efficient. It may also mean it is becoming more skilled at extracting value from a system that is already fragmented and opaque.

Healthcare is especially prone to this illusion because the output is hard to measure. If you run a factory, efficiency is visible in units per hour, defect rates, and margins. If you run a medical network, the output is more ambiguous. Did the higher reimbursement buy better access, or just higher billing? Did hospital affiliation reduce fragmentation, or merely shift leverage upward? Did consolidation improve coordination, or just increase the size of the invoice?

A useful mental model here is the difference between clinical efficiency and financial efficiency.

• Clinical efficiency asks: did the patient get the right care at the right time with the least friction?
• Financial efficiency asks: did the organization capture and retain revenue effectively?

These are not the same. In healthcare, they can diverge sharply. A system can become financially efficient by directing more visits, services, or billing through controlled channels, while becoming clinically less efficient because access narrows, independence declines, and incentives become more complex.

That is why a consolidation wave can feel stabilizing to executives and unsettling to patients at the same time. From the boardroom, scale reduces uncertainty. From the exam room, scale can mean longer wait times, less choice, and more administrative friction.

The system may be optimizing for revenue capture while quietly degrading the simplicity of care.

---

The new question is not who owns care, but who controls the algorithm of care

If the old debate was about private versus public, or insurer versus provider, the newer and more important debate is about control of care pathways. The organization that controls referrals, scheduling, billing, network status, and site of care often controls the economics as well.

This is why hospital affiliation matters so much. It changes where a patient begins, where they are sent next, what gets billed, and which organizational layer collects the margin. It also changes how much the practice resembles an independent clinical decision maker versus a node in a larger revenue system. Once that shift happens, the economics become self reinforcing.

Imagine a city where every road is privately owned and every turn incurs a different fee. Driving from home to work may still happen, but the route becomes more expensive, more centralized, and more predictable for the owners of the roads. That is how healthcare consolidation works. The patient is still moving through the system, but the path has become monetized at more points.

This is also why it is too simplistic to say that higher reimbursement is always bad or that consolidation is always inefficient. Some integration can reduce duplicated tests, improve data sharing, and help patients with complex conditions. The problem is not scale itself. The problem is when scale becomes a license to reprice access without a corresponding improvement in outcomes.

The challenge for the next decade is therefore not just antitrust or cost control. It is the design of incentives that reward better coordination without rewarding mere dominance. That is a much harder task. Dominance is easy to measure. Coordination is not.

---

Key Takeaways

1. Follow the pathway, not just the provider. The most important healthcare economics happen at the handoff points: referrals, site of care, contracting, and ownership.

2. Do not confuse financial efficiency with patient efficiency. A stronger operating margin can reflect better care, but it can also reflect better extraction from a fragmented system.

3. Reimbursement premiums are compounding advantages. An 11 percent premium for hospital affiliated practices is not a rounding error. It can finance further consolidation and reinforce market power.

4. Ask who benefits from complexity. If care becomes harder to navigate while large organizations become more profitable, the system may be optimizing for capture, not clarity.

5. Measure outcomes, not just structure. Consolidation is only worth defending if it reliably produces better access, lower total cost, or superior health results.

---

What this means for investors, operators, and patients

For investors, the lesson is to look beyond headline growth and ask where the margin is coming from. Is it coming from better care delivery, better mix, stronger pricing, or control over the care network? Those are very different engines, and they have very different durability.

For operators, the challenge is to recognize that ownership alone is not a strategy. The real strategic asset is the ability to coordinate care without turning every coordination point into a toll booth. The best healthcare organizations of the future may be the ones that can prove they create value while resisting the temptation to monetize every inch of the pathway.

For patients, the practical implication is even simpler: the more care is centralized, the more important it becomes to understand where decisions are being made. If your primary care practice is hospital affiliated, the incentives around referrals, testing, and follow up may differ from those in a truly independent setting. That does not automatically make the care worse. It does mean the structure is shaping the experience in ways most people never see.

This is the real story hiding inside the numbers. Healthcare is not merely becoming more expensive because medicine is advancing or people are older. It is becoming more expensive because the system increasingly pays for ownership of the route. That is a very different problem, and it requires a very different solution.

Conclusion: healthcare is paying more for coordination, but not necessarily buying more health

The deepest paradox in modern healthcare is that consolidation is often justified as a cure for chaos, yet the pricing it creates can intensify the very complexity it claims to solve. A system can look more organized from above while becoming more expensive, less transparent, and harder to navigate from below.

So the next time you see a strong earnings report or a rising reimbursement premium, do not ask only whether the organization is getting bigger. Ask a better question: Is it becoming more capable of healing, or simply more capable of collecting?

That distinction may be the most important one in healthcare.